Warning letter
Burnham Laboratories, Inc.: warning letter of Oct 15, 2001
FDA warning letter UCM178322 · Chicago District Office
Key facts
| Reference number | UCM178322 |
|---|---|
| Company | Burnham Laboratories, Inc. |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 15, 2001 |
| Posted date | Oct 15, 2001 |
| Issuing office | Chicago District Office |
| Product type | Drugs |
| CFR sections cited | 211.84(d)(2), 211.67(b), 211 |
| Country | 3 |
| Inspection city | Niles |
| Inspection ZIP | 60714-4617 |
| Inspection start date | Aug 21, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: